FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula (I), a pharmaceutically acceptable salt or ester thereof. Compounds of formula (I) modulate activity of cannabinoid receptor 2 (CB2).
.
In formula (I) R1 is a halophenyl or C3-C6-cycloalkyl-C1-C6-alkoxy; R2 is a C3-C6-cycloalkyl, azetidinyl or difluoroazetidinyl; one of R3 and R4 is hydrogen, and other is -(CR5R6)-R7 or -A-R7; or R2 is a C3-C6-cycloalkyl, and R3 and R4 together with a nitrogen atom, to which they are bonded, form piperidinylamine; R5 and6 are independently selected from hydrogen, C1-C6-alkyl, halogen-C1-C6-alkyl, C3-C6-cycloalkyl, C3-C6-cycloalkyl-C1-C6-alkyl, phenyl, phenyl-C1-C6-alkyl and halophenyl; or R5 and6 together with carbon atom, to which they are bonded, form C3-C6-cycloalkyl or oxetanyl; R7 is cyano, carboxy, 5-methyl-[1,2,4]oxadiazol-3-yl, 5-amino-[1,2,4]oxadiazol-3-yl, thiazolyl, C1-C6-alkylthiazolyl, pyridinyl, C1-C6-alkylaminocarbonyl, hydroxy-C1-C6-alkyl, C1-C6-alkoxy-C1-C6-alkyl, aminocarbonyl, C1-C6-alkoxycarbonyl, di-C1-C6-alkylaminocarbonyl, phenyl-C1-C6-alkyl, pyridinyl-C1-C6-alkyl, halogen-C1-C6-alkylaminocarbonyl, 5-phenyl-2-methyl-oxazol-4-yl-alkyl, aminocarbonyl-C1-C6-alkyl or halogen; and A is cyclohexyl or thiophenyl, under condition specified in patent claim. Invention also relates to individual compounds, pharmaceutical composition, use of compounds and to a method of modulating CB2 receptor activity.
EFFECT: technical result is obtaining novel compounds of formula (I) modulating activity of cannabinoid receptor 2 (CB2).
19 cl, 111 ex
Title | Year | Author | Number |
---|---|---|---|
PHENYL DERIVATIVES AS CANNABINOID RECEPTOR 2 AGONISTS | 2016 |
|
RU2728823C1 |
PYRIDINES SUBSTITUTED WITH HETEROARYL AND APPLICATION METHODS | 2017 |
|
RU2756743C2 |
SPIROCYCLIC NITRILES AS PROTEASE INHIBITORS | 2012 |
|
RU2621695C2 |
SPIROCYCLIC NITRILES AS PROTEASE INHIBITORS | 2007 |
|
RU2478620C2 |
NEW DERIVATIVES OF 3,3-DIMETHYLTETRAHYDROQUINOLINE | 2011 |
|
RU2603276C2 |
NEW COMPOUNDS AND COMPOSITIONS FOR CATHEPSIN INHIBITION | 2004 |
|
RU2346943C2 |
NEW ETERIAL DERIVATIVES OF ISOXAZOLE AS POSITIVE ALLOSTERIC MODULATORS OF THE GABA A ALFA 5 RECEPTOR | 2017 |
|
RU2772862C2 |
NEW BICYCLIC COMPOUNDS OF THIOPHENYLAMIDE | 2013 |
|
RU2644565C2 |
PYRROLOPYRAZINE KINASE INHIBITORS | 2012 |
|
RU2673064C2 |
SUBSTITUTED TRICYCLIC COMPOUNDS AND METHOD OF APPLICATION | 2016 |
|
RU2744766C2 |
Authors
Dates
2017-03-02—Published
2012-10-25—Filed